OneMedNet (NASDAQ:ONMD – Get Free Report) released its earnings results on Monday. The company reported ($0.43) earnings per share for the quarter, Zacks reports. The company had revenue of $1.02 million for the quarter.
OneMedNet Trading Down 11.4%
Shares of NASDAQ ONMD traded down $0.56 during trading on Wednesday, reaching $4.39. 12,623 shares of the company traded hands, compared to its average volume of 164,360. The stock has a market cap of $26.01 million, a P/E ratio of -2.74 and a beta of 1.25. The firm’s fifty day simple moving average is $5.31 and its 200 day simple moving average is $6.95. OneMedNet has a 12-month low of $3.61 and a 12-month high of $23.00.
Analyst Ratings Changes
Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has a consensus rating of “Sell”.
Check Out Our Latest Stock Report on OneMedNet
Insider Activity at OneMedNet
In other OneMedNet news, Director Thomas Kosasa acquired 129,758 shares of the firm’s stock in a transaction that occurred on Wednesday, October 7th. The shares were purchased at an average cost of $5.78 per share, for a total transaction of $750,001.24. Following the completion of the acquisition, the director owned 1,983,573 shares of the company’s stock, valued at approximately $11,465,051.94. The trade was a 7.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Jeffrey Yu purchased 45,126 shares of OneMedNet stock in a transaction dated Friday, October 9th. The shares were acquired at an average cost of $5.54 per share, for a total transaction of $249,998.04. Following the transaction, the insider directly owned 896,840 shares of the company’s stock, valued at approximately $4,968,493.60. This represents a 5.30% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders bought 189,169 shares of company stock valued at $1,089,995 and sold 15,167 shares valued at $103,042. 50.20% of the stock is currently owned by insiders.
About OneMedNet
OneMedNet Corporation provides real-world data (RWD) for healthcare research. Through its iRWD platform, the company helps connect healthcare organizations that contribute medical information with pharmaceutical, biotechnology and medical-device companies seeking data for research and product development. Its offerings include curated, de-identified clinical records and medical imaging data. These datasets can support activities such as clinical research and the evaluation of medicines and medical devices, while the platform is designed to facilitate secure data access and collaboration.
Read More
- Five stocks we like better than OneMedNet
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
